Altered Fovea in AQP4-Igg–Seropositive Neuromyelitis Optica Spectrum Disorders E805
Total Page:16
File Type:pdf, Size:1020Kb
Volume 7, Number 5, September 2020 Neurology.org/NN A peer-reviewed clinical and translational neurology open access journal ARTICLE Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders e805 ARTICLE Treatment and outcome of aquaporin-4 antibody–positive NMOSD: A multinational pediatric study e837 ARTICLE Guillain-Barré syndrome: Th e fi rst documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offi ng e781 ARTICLE Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond? e825 Academy Officers Neurology® is a registered trademark of the American Academy of Neurology (registration valid in the United States). James C. Stevens, MD, FAAN, President Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is an Orly Avitzur, MD, MBA, FAAN, President Elect open access journal published online for the American Academy of Neurology, Ann H. Tilton, MD, FAAN, Vice President 201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at 14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices are Carlayne E. Jackson, MD, FAAN, Secretary located at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103. Production offices are located at 351 West Camden Street, Baltimore, MD Janis M. Miyasaki, MD, MEd, FRCPC, FAAN, Treasurer 21201-2436. © 2020 American Academy of Neurology. Ralph L. Sacco, MD, MS, FAAN, Past President Neurology® Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology. Journal website: Neurology.org/NN, AAN website: AAN.com CEO, American Academy of Neurology Copyright and Permission Information: Please go to the journal website Mary E. Post, MBA, CAE (www.neurology.org/nn) and click the Permissions tab for the relevant article. Chief Executive Officer Alternatively, send an email to [email protected]. General information about permissions can be found here: https://www.lww.com/ 201 Chicago Ave journal-permission. Minneapolis, MN 55415 Disclaimer: Opinions expressed by the authors and advertisers are not necessarily those of the American Academy of Neurology, its affiliates, or of Tel: 612-928-6100 the Publisher. The American Academy of Neurology, its affiliates, and the Publisher disclaim any liability to any party for the accuracy, completeness, efficacy, or availability of the material contained in this publication (including Editorial Office drug dosages) or for any damages arising out of the use or non-use of any of the Patricia K. Baskin, MS, Executive Editor material contained in this publication. Rachel A. Anderson, Administrative Assistant Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, New York, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax: 973-215-2485, [email protected] and in Europe: Craig Silver, tel: +44 7855 Morgan S. Sorenson, Managing Editor 062 550 or e-mail: [email protected]. fl Careers & Events: Monique McLaughlin, Wolters Kluwer, Two Commerce Neurology® Neuroimmunology & Neuroin ammation Square, 2001 Market Street, Philadelphia, PA 19103, tel: (215)-521- 8468, fax: Neurology® Genetics 215-521-8801; [email protected]. Reprints: Meredith Edelman, Commercial Reprint Sales, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel: Kathleen M. Pieper, Senior Managing Editor, Neurology® 215-356-2721; [email protected]; reprintsolutions@ Karen Skaja, Senior Editorial Coordinator wolterskluwer.com. Skyler M. Kane, Editorial Coordinator Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8638, Margaret A. Rei, Editorial Coordinator [email protected]. International: Andrew Wible, Senior Manager, Rights, Licensing, and Partnerships, Wolters Kluwer, translationrights@ wolterskluwer.com. Lee Ann Kleffman, Managing Editor, Neurology® Clinical Practice Andrea Rahkola, Production Editor Kristen Swendsrud, Production Coordinator Sharon L. Quimby, Digital Managing Editor Kaitlyn Aman Ramm, Digital Multimedia/Graphics Coordinator Justin Daugherty, Digital Multimedia/Podcast Coordinator Madeleine Sendek, MPH, Digital Marketing Communications Coordinator Publisher Wolters Kluwer Baltimore, MD Publishing Staff Sarah Carrera, MBA, Executive Publisher Jessica Heise, Production Team Leader, Neurology Journals Megen Miller, Production Editor Stacy Drossner, Production Associate Copyright © 2020 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. A peer-reviewed clinical and translational neurology open access journal Neurology.org/NN Neurology® Neuroimmunology & Neuroinflammation Editor JosepO.Dalmau,MD,PhD Vision Neurology® Neuroimmunology & Neuroinflammation will be the premier Deputy Editor peer-reviewed journal in the fields of Scott S. Zamvil, MD, PhD, FAAN neuroimmunology and neuroinflammation. Associate Editors Marinos Dalakas, MD, FAAN Mission Neurology: Neuroimmunology & Michael Heneka, MD Neuroinflammation will provide neurologists Dennis Kolson, MD, PhD and clinical research scientists with Friedmann Paul, MD outstanding peer-reviewed articles, editorials, Editorial Board and reviews to enhance patient care and Rohit Aggarwal, MD, MS Jun Li, MD, PhD facilitate basic and translational research. Sergio E. Baranzini, PhD Lin Mei, MD, PhD Susanne Benseler, MD Andrew McKeon, MD Jeffrey L. Bennett, MD, PhD, FAAN Christopher Power, MD Editorial Tel: 612-928-6400 S´everine Boill´ee, PhD Richard M. Ransohoff,MD Inquiries Toll-free: 800-957-3182 (US) Matthijs C. Brouwer, MD, PhD Christine Stadelmann, MD Fax: 612-454-2748 Wolfgang Br¨uck, MD Israel Steiner, MD [email protected] David B. Clifford, MD, FAAN Lawrence Steinman, MD Russell C. Dale, MBChB, MRCP, PhD Jesper Tegn´er, PhD, MSc Oscar H. Del Brutto, MD, FAAN Silvia N. Tenembaum, MD Stay facebook.com/NeurologyNN Thomas G. Forsthuber, MD Maarten J. Titulaer, MD, PhD Connected Kazuo Fujihara, MD Ari Waisman, PhD twitter.com/greenjournal Jeffrey M. Gelfand, MD, MAS, FAAN Hugh J. Willison, MBBS, PhD Joseph El Khoury, MD Gregory F. Wu, MD, PhD youtube.com/user/NeurologyJournal Markus P. Kummer, PhD instagram.com/aanbrain Neurology® Journals Editor-in-Chief Classification of Evidence Review Team Jos´eG.Merino,MD,MPhil,FAAN Melissa J. Armstrong, MD Richard L. Barbano, MD, PhD, FAAN Deputy Editor Richard M. Dubinsky, MD, MPH, FAAN Olga Ciccarelli, MD, PhD, FRCP Jeffrey J. Fletcher, MD, MSc Gary M. Franklin, MD, MPH, FAAN Section Editors David S. Gloss II, MD, MPH&TM Biostatistics John J. Halperin, MD, FAAN Richard J. Kryscio, PhD Jason Lazarou, MSc, MD Sue Leurgans, PhD Steven R. Mess´e, MD, FAAN V. Shane Pankratz, PhD Pushpa Narayanaswami, MBBS, DM, FAAN Alex Rae-Grant, MD Classification of Evidence Evaluations Gary S. Gronseth, MD, FAAN Equity, Diversity, & Inclusion RoyH.Hamilton,MD,MS,FAAN Holly E. Hinson, MD, MCR, FAAN Podcasts Stacey L. Clardy, MD, PhD, FAAN Jeffrey B. Ratliff, MD, Deputy Podcast Editor Ombudsman Jonathan W. Mink, MD, PhD, FAAN Scientific Integrity Advisor David S. Knopman, MD, FAAN Copyright © 2020 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. TABLE OF CONTENTS Volume 7, Number 5, September 2020 Neurology.org/NN e807 Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS H.-P. Hartung, on behalf of the ENSEMBLE Steering Committee members and study investigators Open Access Class of Evidence e805 Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders S. Motamedi, F.C. Oertel, S.K. Yadav, E.M. Kadas, M. Weise, J. Havla, Cover Image M. Ringelstein, O. Aktas, P. Albrecht, K. Ruprecht, J. Bellmann-Strobl, 3D foveal shape analysis method overview. The left panel shows inner H.G. Zimmermann, F. Paul, and A.U. Brandt limiting membrane surface smoothing and radial reconstruction using the Open Access cubic Bezier polynomial. The right panel shows rim disk (blue), slope fl e809 Recent cannabis use in HIV is associated with reduced disk (red), and pit at disk (green). The lower panel shows rim height, fl average pit depth, and central foveal thickness. Stylized by Kaitlyn Aman in ammatory markers in CSF and blood Ramm, Digital Multimedia/Graphics Coordinator. R.J. Ellis, S.N. Peterson, Y. Li, R. Schrier, J. Iudicello, S. Letendre, E. Morgan, B. Tang, I. Grant, and M. Cherner See page e805 Open Access Editor’s Corner e817 Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy e858 N2 in the time of COVID-19 L. Appeltshauser, A.-M. Brunder, A. Heinius, P. Kortv¨ ´elyessy, J. Dalmau K.-P. Wandinger, R. Junker, C. Villmann, C. Sommer, F. Leypoldt, and K. Doppler Open Access Open Access Editorial, p. e843 Editorial e815 CSF chitinase 3-like-1 association with disability of e843 Isotyping paranodal antibodies in inflammatory primary progressive MS neuropathies: One step closer to precision care F. P´erez-Miralles, D. Prefasi, A. Garc´ıa-Merino, F. Gascon-Gim´ ´enez, N. Medrano, J. Castillo-Villalba, L. Cubas, C. Alcal´a, S. Gil-Perot´ın, C. Lleix`a and L. Querol R. Gomez-Ballesteros,´ J. Maurino, E. Alvarez-Garc´ ´ıa, and Open Access B. Casanova Open Access Class of Evidence Articles e819 Painful trigeminal neuropathy associated with e781 Guillain-Barr´e syndrome: The first documented anti-Plexin D1 antibody COVID-19–triggered autoimmune neurologic T. Fujii, R. Yamasaki, Y. Miyachi, K. Iinuma, Y. Hashimoto, N. Isobe,